The financials
CME Group by the numbers
CME Group (CME) reported revenue of $1.71B in Q2 2026 (quarter ended June 30, 2026), up 0.8% from the same quarter a year earlier. That came with net income of $1.04B (61% of revenue). For the full year FY2025, revenue was $6.52B (+6.4% year on year) and net income $4.07B. Its largest product in 2026-Q2 was Clearingandtransactionfees at $1.35B, 79% of the disclosed total, just ahead of Market Data at 14%.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $1.71B | $1.69B | +0.8% |
| Operating income | $1.11B | $1.13B | −2.0% |
| Net income | $1.04B | $1.03B | +1.6% |
| Diluted EPS | $2.88 | $2.81 | +2.5% |
| Product | Revenue | Share |
|---|---|---|
| Clearingandtransactionfees | $1.35B | 79% |
| Market Data | $238M | 14% |
| Other | $116M | 6.8% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q2 2026Total $1.71B (-9.2%)
Market Data grew +20% year on yearClearingandtransactionfees -2.6% year on year
Segment Latestquarter on quarteryear on year
- Clearingandtransactionfees$1.35B$1.35BQoQ -12%year on year -2.6%-12%-2.6%
- Market Data$238.1M$238.1MQoQ +6.2%year on year +20%+6.2%+20%
- Other$115.6M$115.6MQoQ +1.9%year on year +9.2%+1.9%+9.2%
Financial Data & Stock Exchanges
Ranks #3 of 11 by Smart Score